In the Media

Talks/Podcasts

How does the immune system work? (Podcast in German by Grams‘ Sprechstunde at Detektor.fm, 7 July 2022)

Coronavirus Update Special episode about Hybrid immunity (Podcast in German by NDR, 21 June 2022)

Vaccines for COVID-19 (talk in German by Leif Erik Sander, 06 Jan 2021)

How well do the vaccines really protect? (Podcast in German by rbb24, 13 Jan 2021)

How do the vaccines against SARS-CoV-2 work? (Podcast in German by the Berlin Institute of Health, 03 Mar 2021)

Efficacy, order, side effects – questions about Corona vaccination (Interview in German by Leif Erik Sander, 22 Apr 2021)

 

News(paper)

„Unfortunately, it is not possible to give a complete all-clear yet“ (Interview in German by RedaktionsNetzwerk Deutschland, 8 Aug 2022)

„Can the spread of monkeypox still be stopped, Mr. Sander?“ (Interview by SpiegelOnline, 10 June 2022)

„The Corona vaccination does not change your genetic material“ (Interview in German by Zeit Online, 21 Jan 2021)

Mixing vaccines may boost immune responses (The Lab is featured in an article by Gretchen Vogel; Science, 11 Jun 2021)

Mix-and-match COVID vaccines: the case is growing, but questions remain (Article by Dyani Lewis about our current research; Nature 595, 344-345, 01 July 2021)

Corona: „Would have my children vaccinated“ (Interview by ZDF heute, 04 July 2021)

 

Current Articles/Preprints

Aznaourova, M. et al. Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19. Proceedings of the National Academy of Sciences of the United States of America 119

Gruell, H. et al. Neutralization sensitivity of the SARS-CoV-2 Omicron BA.2.75 sublineage (Preprint)

Gruell, H. et al. SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns. Cell host & microbe

Gruell, H. et al. mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant. Nature medicine

Tober-Lau, P. et al. Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers. The Lancet Respiratory Medicine 9, e104-e105

Tober-Lau, P. et al. Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections. Emerging Infectious Diseases  28.

Vanshylla, K. et al. Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults. The Lancet Infectious Diseases 22